Chlamydia Research Today is a free monthly online journal that collates and summarizes the latest research about Chlamydia, including details on symptoms, diagnosis, treatment, causes, problems.

Volume 2 (2005), Issue 7 (July)

1. Serum C-reactive protein and Chlamydia trachomatis antibodies in preterm delivery.
   Obstet Gynecol, 106(1): 73-80. [Abstract] [Full-text]
2. Audit of treatment and contact-tracing rates in immediate (presumptive) versus delayed (polymerase chain reaction) diagnosis of chlamydial infection.
   Int J STD AIDS, 16(7): 502-3. [Abstract] [Full-text]
3. An audit of Chlamydia trachomatis screening in colposcopy--Hartlepool experience.
   Int J STD AIDS, 16(7): 500-1. [Abstract] [Full-text]
4. The management of Chlamydia trachomatis in genitourinary medicine clinics: a national audit in 2004.
   Int J STD AIDS, 16(7): 494-9. [Abstract] [Full-text]
5. Correlates of sexually transmitted infections in young Australian women.
   Int J STD AIDS, 16(7): 482-7. [Abstract] [Full-text]
6. Acceptability of azithromycin for the control of trachoma in Northern Tanzania.
   Trans R Soc Trop Med Hyg, 99(9): 656-63. [Abstract] [Full-text]
7. Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection.
   Cell Microbiol, 7(8): 1099-108. [Abstract] [Full-text]
8. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease.
   Eur J Clin Invest, 35(7): 431-7. [Abstract] [Full-text]
9. Fabrication and optimization of the multiplex PCR-based oligonucleotide microarray for detection of Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum.
   J Microbiol Methods, 62(2): 245-56. [Abstract] [Full-text]
10. Cost-effectiveness of trachoma control in seven world regions.
    Ophthalmic Epidemiol, 12(2): 91-101. [Abstract] [Full-text]
11. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma.
    J Infect Dis, 192(4): 591-9. [Abstract] [Full-text]
12. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
    Andrologia, 37(2): 61-4. [Abstract] [Full-text]
13. Surgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial methodology.
    Ophthalmic Epidemiol, 12(4): 279-86. [Abstract] [Full-text]
14. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.
    Infect Immun, 73(8): 4823-33. [Abstract] [Full-text]
15. Chlamydia conjunctivitis and central retinal vein occlusion.
    Am J Ophthalmol, 140(1): 161-2. [Abstract] [Full-text]
16. Bacteria-associated fibronectin does not enhance Chlamydia trachomatis infectivity in vitro.
    Microb Pathog, 39(1): 53-5. [Abstract] [Full-text]
17. Participatory evaluations of trachoma control programmes in eight countries.
    Trop Med Int Health, 10(8): 764-72. [Abstract] [Full-text]
18. Chlamydial IFN-gamma immune evasion is linked to host infection tropism.
    Proc Natl Acad Sci U S A, 102(30): 10658-63. [Abstract] [Full-text]
19. Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells.
    FEMS Immunol Med Microbiol, 45(2): 113-20. [Abstract] [Full-text]

© 2004-2008 Chlamydia Research Today. All Rights Reserved.